KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Long-Term Debt Repayments (2016 - 2025)

Merck (MRK) has disclosed Long-Term Debt Repayments for 16 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments fell 99.63% to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 billion, a 94.03% increase, with the full-year FY2025 number at $2.5 billion, up 94.03% from a year prior.
  • Long-Term Debt Repayments was $2.0 million for Q4 2025 at Merck, up from $1.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $2.5 billion in Q1 2025 to a low of $1.0 million in Q4 2022.
  • A 5-year average of $722.7 million and a median of $645.0 million in 2024 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: plummeted 99.92% in 2023, then skyrocketed 75000.0% in 2024.
  • Merck's Long-Term Debt Repayments stood at $1.2 billion in 2021, then tumbled by 99.91% to $1.0 million in 2022, then surged by 200.0% to $3.0 million in 2023, then skyrocketed by 17866.67% to $539.0 million in 2024, then plummeted by 99.63% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Long-Term Debt Repayments are $2.0 million (Q4 2025), $1.0 million (Q3 2025), and $2.5 billion (Q1 2025).